IL-10 knockdown resulted in induction of the lytic cycle and enhanced tumor cell destruction in both gastric cancer and LCLs when performed in combination with doxorubicin, suggesting that this tendency towards increased IL-10 expression can be targeted to treat EBV-associated tumors (215). The gene discussed is IL10; the disease is gastric cancer.